Biological age acceleration predicts osteoporosis and reduced longevity in a large prospective cohort
Bone · 2025-11 · 200 · 117609
DOI: 10.1016/j.bone.2025.117609 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bone, 2025-11. Verfasst von Rui Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Center of Regenerative Medicine, Renmin Hospital of Wuhan University, Wuhan 430060, China. Hauptthemen laut MEDLINE: Osteoporosis, Longevity, Aging. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The University of Sydney.
Abstract (Originalsprache)
BACKGROUND: Osteoporosis is a major age-related musculoskeletal condition, yet chronological age does not fully capture individual risk. Biological age acceleration (BAA), as a biomarker of systemic aging, may offer greater predictive value for osteoporosis and lifespan loss. METHODS: We analyzed data from 293,224 participants in the UK Biobank cohort who were free of osteoporosis at baseline. BAA was estimated using two validated models-Klemera-Doubal Method Biological Age (KDM-BA) and PhenoAge. Polygenic risk scores (PRS) were used to account for genetic susceptibility. Multivariable Cox models examined associations of BAA and PRS with incident osteoporosis and all-cause mortality. RESULTS: Over a median follow-up of 8.5 years, 9780 participants developed osteoporosis. Each one standard deviation (SD) increase in KDM-BA and PhenoAge acceleration was associated with a 22.6 % (95 % CI: 1.11, 1.36) and 19.3 % (95 % CI: 1.12, 1.36) higher risk of osteoporosis, respectively. Participants in the highest tertile of BAA had a 38-43 % increased risk compared to those in the lowest tertile. Individuals with both high BAA and high PRS had nearly threefold higher osteoporosis risk, indicating a strong additive effect. Accelerated aging was also linked to a 1.3-1.8-year reduction in life expectancy at age 45, independent of osteoporosis status. CONCLUSION: Accelerated biological aging is an independent predictor of osteoporosis and premature mortality. Integration of BAA into clinical assessment could enhance early identification of at-risk individuals and support aging-targeted interventions for skeletal health.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center of Regenerative Medicine, Renmin Hospital of Wuhan University, Wuhan 430060, China.
- Department of Ophthalmology, Renmin Hospital of Wuhan University, Wuhan 430060, China.
- Center of Regenerative Medicine, Renmin Hospital of Wuhan University, Wuhan 430060, China; Sydney Dental School, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2006, Australia. Electronic address:…
Förderung
- The University of Sydney
Zitieren
APA
Zhang, R., Zhong, W., Gao, Y., Duan, X., & Ye, Q. (2025). Biological age acceleration predicts osteoporosis and reduced longevity in a large prospective cohort. Bone, 200, 117609. https://doi.org/10.1016/j.bone.2025.117609
Vancouver
Zhang R, Zhong W, Gao Y, Duan X, Ye Q. Biological age acceleration predicts osteoporosis and reduced longevity in a large prospective cohort. Bone. 2025;200:117609. doi:10.1016/j.bone.2025.117609
BibTeX
@article{Zhang2025,
author = {Zhang, Rui and Zhong, Wanyang and Gao, Yuelan and Duan, Xingxiang and Ye, Qingsong},
title = {Biological age acceleration predicts osteoporosis and reduced longevity in a large prospective cohort},
journal = {Bone},
year = {2025},
volume = {200},
pages = {117609},
doi = {10.1016/j.bone.2025.117609}
}
EUVIMED